Liquidia (LQDA) EBT Margin Growth (3y) (2023 - 2026)
Powered by 
Analysis
Liquidia (LQDA) EBT Margin Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 646.43 Bn | 625.67 Bn | 17.26 Bn | -265.00 |
| 2 | AbbVie | 442.46 Bn | 435.89 Bn | 12.70 Bn | 636.00 |
| 3 | Merck | 366.77 Bn | 359.63 Bn | 12.21 Bn | 3,137.00 |
| 4 | Novartis Ag | 266.59 Bn | 258.90 Bn | 11.24 Bn | 625.00 |
| 5 | Pfizer | 159.14 Bn | 147.45 Bn | 10.94 Bn | -2,179.00 |
| 6 | Sanofi | 52.40 Bn | 45.02 Bn | 10.79 Bn | -977.00 |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 1,581.00 |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn | -861.00 |
| 10 | Liquidia | 6.11 Bn | 5.82 Bn | 160.92 Mn | 53,896.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 53,896.00 |
| Mar 31, 2026 | 25,271.00 |
| Dec 31, 2025 | 13,770.00 |
| Sep 30, 2025 | 28,077.00 |
| Jun 30, 2025 | -22,939.00 |
| Mar 31, 2025 | -80,170.00 |
| Dec 31, 2024 | -96,053.00 |
| Sep 30, 2024 | -46,858.00 |
| Jun 30, 2024 | -58,942.00 |
| Mar 31, 2024 | -71,617.00 |
| Dec 31, 2023 | 156,912.00 |